Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$2.58 - $3.36 $42,668 - $55,567
-16,538 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$3.02 - $5.16 $3,020 - $5,160
1,000 Added 6.44%
16,538 $55,000
Q3 2020

Nov 19, 2020

BUY
$3.01 - $3.88 $46,769 - $60,287
15,538 New
15,538 $49,000
Q2 2020

Aug 14, 2020

SELL
$2.33 - $4.6 $36,203 - $71,474
-15,538 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$2.57 - $4.08 $10,280 - $16,320
4,000 Added 34.67%
15,538 $63,000
Q3 2019

Nov 15, 2019

BUY
$2.74 - $4.65 $31,614 - $53,651
11,538 New
11,538 $13,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $20M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.